These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1559308)

  • 21. A population pharmacokinetic analysis of the influence of nutritional status of digoxin in hospitalized Korean patients.
    Choi SA; Yun HY; Lee ES; Shin WG
    Clin Ther; 2014 Mar; 36(3):389-400. PubMed ID: 24612944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of quinidine on digoxin kinetics in cardiac patients.
    Pedersen KE; Hastrup J; Hvidt S
    Acta Med Scand; 1980; 207(4):291-5. PubMed ID: 7386224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive performance of serum digoxin concentration in patients with congestive heart failure by a hyperbolic model based on creatinine clearance.
    Konishi H; Shimizu S; Chiba M; Minouchi T; Koida M; Yamaji A
    J Clin Pharm Ther; 2002 Aug; 27(4):257-65. PubMed ID: 12174027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of quinidine in male patients. A population analysis.
    Verme CN; Ludden TM; Clementi WA; Harris SC
    Clin Pharmacokinet; 1992 Jun; 22(6):468-80. PubMed ID: 1587058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Digoxin-quinidine interaction in patients with chronic renal failure.
    Fenster PE; Hager WD; Perrier D; Powell JR; Graves PE; Michael UF
    Circulation; 1982 Dec; 66(6):1277-80. PubMed ID: 7139903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quinidine-digoxin interaction: time course and pharmacokinetics.
    Leahey EB; Bigger JT; Butler VP; Reiffel JA; O'Connell GC; Scaffidi LE; Rottman JN
    Am J Cardiol; 1981 Dec; 48(6):1141-6. PubMed ID: 7304462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of captopril on pharmacokinetics of digoxin in patients with mild congestive heart failure.
    Miyakawa T; Shionoiri H; Takasaki I; Kobayashi K; Ishii M
    J Cardiovasc Pharmacol; 1991 Apr; 17(4):576-80. PubMed ID: 1711623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction between quinidine and digoxin.
    Leahey EB; Reiffel JA; Drusin RE; Heissenbuttel RH; Lovejoy WP; Bigger JT
    JAMA; 1978 Aug; 240(6):533-4. PubMed ID: 671662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictability of serum digoxin concentrations in clinical practice.
    Taketomo RT; Dominguez AE; Landes RA
    Drug Intell Clin Pharm; 1983 Nov; 17(11):821-5. PubMed ID: 6641506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alteration of digoxin pharmacokinetics by a single dose of quinidine.
    Chen TS; Friedman HS
    JAMA; 1980 Aug; 244(7):669-72. PubMed ID: 6156244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacoepidemiologic detection of calcium channel blocker-induced change on digoxin clearance using multiple trough screen analysis.
    Suematsu F; Yukawa E; Yukawa M; Minemoto M; Ohdo S; Higuchi S; Goto Y
    Biopharm Drug Dispos; 2002 Jul; 23(5):173-81. PubMed ID: 12116048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population pharmacokinetics of digoxin in Egyptian pediatric patients: impact of one data point utilization.
    EL Desoky ES; Nagaraja NV; Derendorf H
    Am J Ther; 2002; 9(6):492-8. PubMed ID: 12424506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Digoxin bioavailability during quinidine administration.
    Hager WD; Mayersohn M; Graves PE
    Clin Pharmacol Ther; 1981 Nov; 30(5):594-9. PubMed ID: 7297019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population-based investigation of relative clearance of digoxin in Japanese neonates and infants by multiple-trough screen analysis.
    Suematsu F; Yukawa E; Yukawa M; Minemoto M; Ohdo S; Higuchi S; Goto Y
    Eur J Clin Pharmacol; 2001 Apr; 57(1):19-24. PubMed ID: 11372585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physiologic pharmacokinetic modeling of gastrointestinal blood flow as a rate-limiting step in the oral absorption of digoxin: implications for patients with congestive heart failure receiving epoprostenol.
    Carlton LD; Pollack GM; Brouwer KL
    J Pharm Sci; 1996 May; 85(5):473-7. PubMed ID: 8742937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Studies on the interaction between digoxin and quinidine by means of monitoring of blood serum drug concentrations].
    Ochotny R; Wierzchowiecki M; Cieśliński A; Grześkowiak A
    Pol Arch Med Wewn; 1980 Jan; 63(1):57-63. PubMed ID: 7360676
    [No Abstract]   [Full Text] [Related]  

  • 37. Digoxin-quinidine interaction in patients with renal failure.
    Hirschberg R; Schaefer K; von Herrath D; Kreutz G; Kewitz H
    Klin Wochenschr; 1981 May; 59(10):521-2. PubMed ID: 7241953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of SLCO4C1 Genotypes, Creatinine, and Spironolactone on Digoxin Population Pharmacokinetic Variables in Patients With Cardiac Insufficiency.
    Du P; Wang A; Ma Y; Jia A; Li Y; Li X
    Clin Ther; 2020 Sep; 42(9):1799-1810.e3. PubMed ID: 32798059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of quinidine on digoxin bioavailability.
    Pedersen KE; Christiansen BD; Klitgaard NA; Nielsen-Kudsk F
    Eur J Clin Pharmacol; 1983; 24(1):41-7. PubMed ID: 6832200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of rifampin on quinidine and digoxin.
    Bussey HI; Merritt GJ; Hill EG
    Arch Intern Med; 1984 May; 144(5):1021-3. PubMed ID: 6712395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.